Treatment of Neuroleptic Malignant Syndrome with Electroconvulsive Therapy in an Adolescent with Psychosis

Tanıdır, Canan; Aksoy, Sena Dilek; Canbek, Özge; Aras, Gizem Funda; Kılıçoğlu, Ali Güven; Erdoğan, Ayten

doi:10.1089/cap.2015.0185

Cited by 8 publications

(2 citation statements)

References 5 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Two reviews by Croarkin et al 100 and Neuhut et al 101 have highlighted the treatment potential for ECT in neuroleptic malignant syndrome (NMS). Case studies have highlighted the possibility to treat NMS with ECT 47–51 . In a comprehensive review, Consoli et al 90 found 59 cases of children and adolescents with catatonia treated with ECT in 31 reports.…”

Section: Resultsmentioning

confidence: 99%

“…Case studies have highlighted the possibility to treat NMS with ECT. [47][48][49][50][51] In a comprehensive review, Consoli et al 90 found 59 cases of children and adolescents with catatonia treated with ECT in 31 reports. They reported a favorable response to ECT for 45 patients, with partial improvement noted in 3 and lack of response in only 1.…”

Section: Evidence For Ect In Catatoniamentioning

confidence: 99%

See 1 more Smart Citation

Electroconvulsive Therapy in Children and Adolescents

Døssing

Pagsberg

2021

J ECT

View full text Add to dashboard Cite

There is a lack of studies regarding the efficacy of electroconvulsive therapy (ECT) in children and adolescents. In this study, we aimed to assess benefits and harms of ECT in children and adolescents with major psychiatric diseases. We conducted a systematic search in PubMed, EMBASE, and PsycINFO for peer-reviewed articles written in English regarding the use of ECT as treatment for major psychiatric diseases in children and adolescents. This study consists of 192 articles, mostly case studies (n = 50), reviews and overview articles (n = 52), and retrospective studies (n = 30). We present an overview of evidence for ECT in children and adolescents with mood disorders, catatonia, schizophrenia, intellectual disability, self-injurious behavior, and other indications. This article is also a summary of international guidelines regarding the use of ECT in children and adolescents. We evaluated the overall quality of evidence by using Grading of Recommendations, Assessment, Development and Evaluations and found the overall level of evidence to be of low quality. There are no absolute contra indications for ECT in children and adolescents. Fears regarding cognitive dysfunction have not been reproduced in studies. Electroconvulsive therapy should be considered in severe, treatment-resistant mood disorders, catatonia, and schizophrenia, especially in older adolescents. High-quality studies are warranted to assess the efficacy of ECT, especially in these potentially life-threatening diseases.

show abstract